Cerebrovascular disease and dementia

International Review of Psychiatry

Volumn 18, Issue 5, 2006, Pages 423-431

  Onyike, Chiadi U ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE;

ALZHEIMER DISEASE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DEMENTIA; DISEASE CLASSIFICATION; HUMAN; LACUNAR INFARCT; LEUKOARAIOSIS; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; DEMENTIA; HUMANS;

EID: 33750617345     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260600935421     Document Type: Review

References (61)

1. Aalten, P., de Vugt, M. E., Jaspers, N., Jolles, J., & Verhey, F. R. (2005). The course of neuropsychiatric symptoms in dementia. Part I: Findings from the two-year longitudinal Maasbed study. International Journal of Geriatric Psychiatry, 20(6), 523-530.
2. Aevarsson, O., & Skoog, I. (1996). A population-based study on the incidence of dementia disorders between 85 and 88 years of age. Journal of the American Geriatrics Society, 44(12), 1455-1460.
3. Andersen, K., Lolk, A., et al. (1997). Prevalence of very mild to severe dementia in Denmark. Acta neurologica Scandinavica, 96(2), 82-87.
4. Aronson, M. K., Ooi, W. L., et al. (1991). Dementia. Age-dependent incidence, prevalence, and mortality in the old old. Archives of Internal Medicine, 151(5), 989-992.
5. Bowler, J. V., Eliasziw, M., et al. (1997). Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Archives of Neurology, 54(6), 697-703.
6. Brayne, C., & Calloway, P. (1989). An epidemiological study of dementia in a rural population of elderly women. The British Journal of Psychiatry, 155, 214-219.
7. CSHA (Canadian Study of Health, & Aging) (1994). Canadian study of health and aging: Study methods and prevalence of dementia. Canadian Medical Association Journal, 150(6), 899-913.
8. Casserly, I., & Topol, E. (2004). Convergence of atherosclerosis and Alzheimer s disease: Inflammation, cholesterol, and misfolded proteins. Lancet, 363(9415), 1139-1146.
9. Chui, H. (2005). Neuropathology lessons in vascular dementia. Alzheimer Disease & Associated Disorders, 19(1), 45-52.
10. Chui, H. C., Mack, W., et al. (2000). Clinical criteria for the diagnosis of vascular dementia: A multicenter study of comparability and inter-rater reliability. Archives of neurology, 57(2), 191-196.
11. Chui, H. C., Victoroff, J. I., et al. (1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology, 42(3 Pt 1), 473-480.
12. DeCarli, C. (2003). The role of cerebrovascular disease in dementia. The Neurologist, 9(3), 123-136.
13. Desmond, D. W., & Tatemichi, T. K. (1998). Vascular dementia. In M. F. Folstein (Ed.), Neurobiology of primary dementia (pp. 167-190). Washington, : American Psychiatric Press, Inc.
14. Di Carlo, A., Baldereschi, M., Amaducci, L., Lepore, V., Bracco, L., Maggi, S., Bonaiuto, S., Perissinotto, E., Scarlato, G., Farchi, G., & Inzitari, D. (2002). Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. Journal of the American Geriatrics Society, 50(1), 41-48.
15. de la Torre, J. C. (2004). Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurology, 3(3), 184-190.
16. Erkinjuntti, T., Inzitari, D., Pantoni, L., Wallin, A., Scheltens, P., Rockwood, K., & Desmond, D. W. (2000). Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution? Annals of the New York Academy of Sciences, 903, 262-272.
17. Erkinjuntti, T., Roman, G., et al. (2004a). Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. Journal of the Neurological Sciences, 226(1-2), 63-66.
18. Erkinjuntti, T., Roman, G., et al. (2004b). Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke: A Journal of Cerebral Circulation, 35(4), 1010-1017.
19. Fitzpatrick, A. L., Kuller, L. H., et al. (2004). Incidence and prevalence of dementia in the Cardiovascular Health Study. Journal of the American Geriatrics Society, 52(2), 195-204.
20. Fratiglioni, L., Viitanen, M., et al. (1997). Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology, 48(1), 132-138.
21. Goulding, J. M., Signorini, D. F., et al. (1999). Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia. Journal of Neurology, Neurosurgery & Psychiatry, 67(5), 654-657.
22. Hachinski, V. C., Iliff, L. D., et al. (1975). Cerebral blood flow in dementia. Archives of Neurology, 32(9), 632-637.
23. Hachinski, V. C., Lassen, N. A., et al. (1974). Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet, 2(7874), 207-210.
24. Hebert, R., Lindsay, J., et al. (2000). Vascular dementia: Incidence and risk factors in the Canadian study of health and aging. Stroke: A Journal of Cerebral Circulation, 31(7), 1487-1493.
25. Heyman, A., Fillenbaum, G. G., et al. (1998). Cerebral infarcts in patients with autopsy-proven Alzheimer s disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology, 51(1), 159-162.
26. Karanja, N. M., Obarzanek, E., et al. (1999). Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial (DASH) Collaborative Research Group. Journal of the American Dietetic Association, 99(8 Suppl), S19-S27.
27. Knopman, D. S. (2006). Dementia and cerebrovascular disease. Mayo Clinic Proceedings, 81(2), 223-230.
28. Knopman, D. S., Rocca, W. A., et al. (2002). Incidence of vascular dementia in Rochester, Minn, 1985-1989. Archives of Neurology, 59(10), 1605-1610.
29. Kovari, E., Gold, E., et al. (2004). Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke: A Journal of Cerebral Circulation, 35(2), 410-414.
30. Leys, D., Pasquier, F., et al. (1998). Epidemiology of vascular dementia. Haemostasis, 28(3-4), 134-150.
31. Lithell, H., Hansson, L., et al. (2003). The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. Journal of Hypertension, 21(5), 875-886.
32. Lopez-Pousa, S., Vilalta-Franch, J., et al. (2004). Incidence of dementia in a rural community in Spain: The Girona cohort study. Neuroepidemiology, 23(4), 170-177.
33. Lopez, O. L., Kuller, L. H., et al. (2005). Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology, 64(9), 1539-1547.
34. Manubens, J. M., Martinez-Lage, J. M., et al. (1995). Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain. Neuroepidemiology, 14(4), 155-164.
35. O'Connor, D. W., Pollitt, P. A., et al. (1989). The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta psychiatrica Scandinavica, 79(2), 190-198.
36. Ott, A., Breteler, M. M., et al. (1998). Incidence and risk of dementia. The Rotterdam Study. American Journal of Epidemiology, 147(6), 574-580.
37. Pohjasvaara, T., Mantyla, R., et al. (2000). Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et 1 Enseignement en Neurosciences. Stroke: A Journal of Cerebral Circulation, 31(12), 2952-2957.
38. Rabins, P. V., Lyketsos, C. G., et al. (2006). Practical dementia care. New York: Oxford University Press.
39. Rocca, W. A., Bonaiuto, S., et al. (1990). Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door-to-door survey in Appignano, Macerata Province, Italy. Neurology, 40(4), 626-631.
40. Rocca, W. A., Hofman, A., et al. (1991). The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group. Annals of Neurology, 30(6), 817-824.
41. Rockwood, K., Bowler, J., et al. (1999). Subtypes of vascular dementia. Alzheimer's Disease & Associated Disorders, 13(Suppl 3), S59-S65.
42. Roman, G. C. (2005). Vascular dementia prevention: A risk factor analysis. Cerebrovascular Diseases (Basel, Switzerland), 20(Suppl 2), 91-100.
43. Roman, G. C., & Royall, D. R. (2004). A diagnostic dilemma: Is Alzheimer's dementia Alzheimer's disease, vascular dementia, or both? Lancet Neurology, 3(3), 141.
44. Roman, G. C., Tatemichi, T. K., et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43(2), 250-260.
45. Rosen, W. G., Terry, R. D., et al. (1980). Pathological verification of ischemic score in differentiation of dementias. Annals of Neurology, 7(5), 486-488.
46. Schneider, L. S., Dagerman, K. S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 294(15), 1934-1943.
47. Skoog, I. (1994). Risk factors for vascular dementia: A review. Dementia, 5(3-4), 137-144.
48. Skoog, I. (1998). Status of risk factors for vascular dementia. Neuroepidemiology, 17(1), 2-9.
49. Skoog, I., Lithell, H., et al. (2005). Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). American Journal of Hypertension, 18(8), 1052-1059.
50. Snowdon, D. A., Greiner, L. H., et al. (1997). Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. Journal of the American Medical Association, 277(10), 813-817.
51. Steinberg, M., Tschanz, J. T., et al. (2004). The persistence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 19(1), 19-26.
52. Tzourio, C., Anderson, C., et al. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163(9), 1069-1075.
53. USDA (United States Department of Agriculture). MyPyramid food guidance system, United States Department of Agriculture; 2005.
54. USDHHS (U.S. Department of Health and Human Services) & USDA. Dietary Guidelines for Americans 2005. U.S. Department of Health and Human Services and U.S. Department of Agriculture; 2005.
55. Ueda, K., Kawano, H., et al. (1992). Prevalence and etiology of dementia in a Japanese community. Stroke: A Journal of Cerebral Circulation, 23(6), 798-803.
56. Verhey, F. R., Lodder, J., et al. (1996). Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology, 15(3), 166-172.
57. Wang, P. S., Schneeweiss, S., et al. (2005). Risk of death in elderly users of conventional versus atypical antipsychotic medications. New England Journal of Medicine, 353(22), 2335-2341.
58. White, L., Petrovitch, H., et al. (2002). Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Annals of the New York Academy of Sciences, 977, 9-23.
59. Yoshitake, T., Kiyohara, Y., et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology, 45(6), 1161-1168.
60. Zekry, D., Hauw, J. J., et al. (2002). Mixed dementia: Epidemiology, diagnosis, and treatment. Journal of the American Geriatrics Society, 50(8), 1431-1438.
61. Zhu, L., Fratiglioni, L., et al. (2000). Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology, 54(11), 2103-2107.